process of discovery in the Zyprexa litigation - with the understanding
that Gottstein would pass it on to Alex Berenson of The New York Times;
-- He knew that these materials painted an incomplete picture of the
issues related to Zyprexa;
-- He did nothing to provide Gottstein or Berenson with information on the
health benefits of Zyprexa; and
-- He knew from experience that this illegal dissemination of materials
would benefit the plaintiffs in the Zyprexa litigation.
Today's agreement applies only to Dr. Egilman. Under it, Dr. Egilman agreed to pay Lilly $100,000.00, which will be donated by Lilly to a charity of its choosing, specifically the International Center for Clubhouse Development. The International Center for Clubhouse Development is a global resource offering communities around the world a more holistic, inspiring and cost-effective solution for issues facing people living with mental illness. The organization's web site is located at http://www.iccd.org.
On February 13, 2007, the Honorable Jack B. Weinstein, Senior Judge of the United States District Court for the Eastern District of New York, issued a permanent injunction against Dr. Egilman and Mr. Gottstein, who, according to the judge, conspired with Berenson of the Times to leak selective confidential Lilly documents to the newspaper.
The Judge's order recognized that the "selective out-of-context" disclosure "may lead to confusion in the patient community and undeserved reputational harm" to Lilly. In addition, it reaffirmed the validity of the confidentiality order, as well as Lilly's designation of its documents as confidential.
Zyprexa is indicated in the United States for the short- and long-term
treatment of schizophrenia, acute mixed and manic episodes of bipolar I
|SOURCE Eli Lilly and Company|
Copyright©2007 PR Newswire.
All rights reserved